Department of Psychiatry and Behavioral Sciences, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
Int J Gynecol Cancer. 2010 Jan;20(1):2-8. doi: 10.1111/IGC.0b013e3181bf7d3f.
To empirically assess and describe the emotional, sexual, and physical impact of cancer-related infertility on gynecologic cancer survivors.
The study was composed of 88 survivors of cervical, endometrial/uterine, ovarian cancer, and gestational trophoblastic disease who experienced impaired or loss of fertility as a result of treatment. Patient age ranged from 21 to 49 years. Participants completed a 1-time self-report survey, including medical and demographic information and empirical measures of mood (Center for Epidemiologic Studies Depression Scale), distress (Impact of Event Scale), sexual function (Female Sexual Function Index), and menopause (Menopausal Symptom Checklist).
Eighty-four (96%) of the 88 enrolled patients had undergone a surgical intervention as part of their cancer treatment. Sixty-three patients (77%) reported clinically significant levels of distress in relation to loss of fertility or impaired fertility. Survivors' levels of distress (P < 0.0001) and depression (P < 0.0001) were associated with the severity and number of menopausal symptoms reported. Patients who retained functioning ovaries (partial fertility) (41%, n = 36) reported being less bothered by menopausal symptoms (P = 0.01) and having higher sexual functioning than those with ovarian failure (P < 0.0001).
The emotional and physical impact of impaired or loss of fertility can be complex and long lasting, with women experiencing high levels of distress, menopausal symptoms, and changes in sexual function persisting into survivorship. Future research should focus on the development of strategies to identify, monitor, and address, in a clinical care setting, the issues these cancer survivors face. Alternate family-building strategies should also be explored before treatment and/or upon treatment completion when feasible.
本研究旨在通过实证评估和描述癌症相关性不孕对妇科癌症幸存者的情绪、性和身体影响。
该研究纳入了 88 名因治疗而导致生育能力受损或丧失的宫颈癌、子宫内膜癌/子宫癌、卵巢癌和妊娠滋养细胞疾病幸存者。患者年龄为 21-49 岁。参与者完成了一次性自我报告调查,包括医疗和人口统计学信息以及情绪(流行病学研究中心抑郁量表)、困扰(事件影响量表)、性功能(女性性功能指数)和更年期(更年期症状清单)的实证测量。
88 名入组患者中,84 名(96%)接受了手术干预作为癌症治疗的一部分。63 名患者(77%)报告了与生育能力受损或丧失相关的临床显著程度的困扰。幸存者的困扰程度(P < 0.0001)和抑郁程度(P < 0.0001)与报告的更年期症状的严重程度和数量相关。保留卵巢功能(部分生育能力)的患者(41%,n = 36)报告更年期症状困扰程度较低(P = 0.01),性功能较高,与卵巢衰竭患者相比(P < 0.0001)。
生育能力受损或丧失的情绪和身体影响可能复杂且持久,女性经历高水平的困扰、更年期症状和性功能改变,持续到生存后阶段。未来的研究应集中于制定策略,以在临床护理环境中识别、监测和解决这些癌症幸存者面临的问题。在治疗前和/或治疗完成时,如果可行,也应探索替代的家庭建设策略。